Abstract
Twenty patients with testicular hydrocele were treated with a new sclerosing therapy consisting of intrascrotal injection of OK-432 (group AStreptococcus pyogenes of human origin). The median observation period after treatment was 6 months (range 2–13 months). Eighteen patients required only one treatment. Two patients had recurrences and received repeat injection. There have been no serious side effects except for fever of 2–3 days' duration and local inflammatory reaction. Sclerotherapy with OK-432 is an efficient and easy method which can be recommended as a primary treatment for hydrocele.
Similar content being viewed by others
References
Nash, J. R.: Sclerotherapy for hydrocele and epididymal cysts.Br. J. Surg., 68, 289 (1979).
Nash, J. R.: Sclerotherapy for hydrocele and epididymal cysts: A five year study.Br. Med. J., 288, 1652 (1984).
Macfarlane, J. R.: Sclerosant therapy for hydroceles and epididymal cysts.Br. J. Urol., 55, 81 (1983).
Hu, K., Khan, A. S., Gonder, M.: Sclerotherapy with tetracycline solution for hydrocele.Urology, 24, 572 (1984).
Badenoch, D. F., Fowler, C. G., Jenkins, B. H.: Aspiration and instillation of tetracycline in the treatment of testicular hydrocele.Br. J. Urol., 5, 172 (1987).
Bullock, N., Thurston, A. V.: Tetracycline sclerotherapy for hydroceles and epididymal cysts.Br. J. Urol., 59, 340 (1987).
Hellstrom, P., Malinen, L., Kontturi, M.: Sclerotherapy for hydroceles and epididymal cysts with ethanolamine oleate.Ann. Chir. Gynaecol., 75, 51 (1986).
Ishida, N., Hoshino, T.: A Streptococcal Preparation as a, Potent Biological Response Modifier OK-432. 2nd ed. Excerpta Medica, Amsterdam 1985, pp. 1–5.
Ishida, N., Hoshino, T.: A Streptococcal Preparation as a Potent Biological Response Modifier OK-432. 2nd ed. Excerpta Medica, Amsterdam 1985, pp. 26–47.
Oshimi, K., Wakasugi, H., Seki, H.: Streptococcal preparation OK-432 augments cytotoxic activity against an erythroleukemic cell line in humans.Cancer Immunol. Immunother. 9, 187 (1980).
Talmadge, J. E., Herberman, R. B.: The preclinical screening laboratory: Evaluation of immunomodulatory and therapeutic properties of biological response modifiers.Cancer Treat. Rep., 70, 171 (1986).
Torisu, M., Fujimura, T., Kato, M.: Successful immunotherapy of carcinomatous pleuritis and peritonitis by intracavitary injection of OK-432. In: Hoshino, T., Uchida, A. (eds.): Clinical and Experimental Studies in Immunotherapy. Excerpta Medica, Amsterdam 1983, pp. 99–112.
Nagao, K.: Studies on treatment of pleural carcinomatosis, with special reference to effect of OK-432.Chiba Med. J., 58, 345 (1982).
Lund, L., Bartolin, J.: Treatment of hydrocele testis with aspiration and injection of polidocanol.J. Urol., 147, 1065 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamamoto, M., Hibi, H. & Miyake, K. A new sclerosant therapy for testicular hydrocele with aspiration and injection of OK-432. Int Urol Nephrol 26, 205–208 (1994). https://doi.org/10.1007/BF02768288
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02768288